在白血病中准细胞周期:"palbociclib 是否改变了游戏规则? ": 一个审查
Muhamad Amir Azizan1, Zainul Abeden1, Nur Haida Natasha Shamsuddin1
1Department of Biomedical Science, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Pulau Pinang, Malaysia.
Medicine
|January 7, 2026
概括
作为一种CDK4/6抑制剂的Palbociclib在白血病治疗方面表现有前途. 本综述分析了这种复杂癌症在临床前和临床研究中的有效性和安全性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 白血病是一种复杂而异质的癌症,治疗进展有限.
- 准分子通路为新型白血病疗法提供了一个有希望的策略.
- 循环素依赖激酶 (CDK) 是细胞循环的关键调节者,并与癌症进展有关.
研究的目的:
- 审查有关palbociclib在白血病中的有效性和安全性的现有文献.
- 评估palbociclib作为一种治疗候选药物,针对白血病中的CDK4/6.
- 探索CDK6在白血病细胞中超出细胞周期进展的作用.
主要方法:
- 对临床前和临床研究的综合文献分析.
- 调查palbociclib作为CDK4/6抑制剂的作用机制.
- 评估palbociclib作为单一治疗和组合治疗的疗效.
主要成果:
- 帕尔博西克利布向CDK4/6,显示出在白血病治疗中的潜力.
- CDK6在白血病细胞中起着至关重要的作用,使其成为重要的治疗点.
- 现有文献表明,palbociclib的有效性和安全性概况需要在白血病中进一步调查.
结论:
- 帕尔博西克利布是白血病的一种有前途的治疗药物,特别针对CDK4/6.
- 需要进一步的临床研究来确定palbociclib在白血病治疗方案中的作用.
- 向CDK6为开发新型白血病疗法提供了一个可行的策略.
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
The Cell Cycle Control System
13.9K
The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
13.9K
The Cell Cycle Control System
5.3K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.3K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K


